Goleta, CA, United States of America

Tambet Teesalu

This inventor holds 14 USPTO granted patents and 1 published patent application and 4 EPO patents. Top assignees: Sanford Burnham Prebys Medical Discovery Institute, Sanford-Burnham Medical Research Institute, Burnham Institute for Medical Research. Active years: 2013-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Tambet Teesalu. Retrieved from https://idiyas.com/inventor/tambet-teesalu

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 14 

% Patents Active = 92.9

 

Average Co-Inventor Count = 3.2

ph-index = 3

Forward Citations = 55(Granted Patents)


Location History:

  • Goleta, CA (US) (2013 - 2022)
  • La Jolla, CA (US) (2019 - 2022)
  • Santa Barbara, CA (US) (2023 - 2024)

Company Filing History:


Years Active: 2013-2026

Loading Chart...
Loading Chart...
14 patents (USPTO):Explore Patents

Title: **Innovations by Inventor Tambet Teesalu**

Introduction

Tambet Teesalu is a prominent inventor based in Goleta, California. With an impressive portfolio of 13 patents, he has significantly contributed to the fields of biomedicine and molecular biology. His innovative approaches focus on developing peptide-based therapies and targeted delivery systems.

Latest Patents

Among his notable patents are methods and compositions utilizing peptides and proteins with C-terminal elements. These inventions disclose compositions and methods that facilitate the targeting and internalization of molecules into specific cells, enhancing their ability to penetrate tissues. Such advancements are critical for delivering therapeutic agents and detectable substances effectively to cells and tissues of interest.

Another significant patent involves a targeted delivery system employing peptides and peptidomimetics that include specific amino acid sequences such as KRGARST and AKRGARSTA. This work encompasses various methods for directing moieties to tumor lymphatic vasculature, imaging those vessels, and methods for reducing tumor metastasis. The inventions also focus on treating cancers and assessing the levels of biological activity associated with gC1q/p32 receptors, which are crucial in numerous disease contexts.

Career Highlights

Tambet Teesalu has made significant strides in his career while working at leading research institutions, including the Sanford Burnham Prebys Medical Discovery Institute and Sanford Burnham Medical Research Institute. His role in these organizations has allowed him to advance his research and patent development significantly, contributing to the biomedical field profoundly.

Collaborations

Throughout his career, Teesalu has collaborated with esteemed colleagues, including Erkki I. Ruoslahti and Kazuki Sugahara. These partnerships have played a vital role in his research endeavors, fostering innovation and broadening the impact of his inventions.

Conclusion

In summary, Tambet Teesalu's inventive work in developing peptide-based methods and targeted delivery systems reflects his commitment to enhancing therapeutic technologies. His contributions, backed by numerous patents, continue to influence the biomedical landscape, paving the way for innovative treatment strategies that could revolutionize patient care.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…